Close Window
Welcome :o)
Welcome to another year exposing the harms of Johnson & Johnson products and the executives that care more about money than human health...
There really is a highly effective way to put an end to mass tort lawsuits: GET JOHNSON & JOHNSON AND SUBSIDIARY KNOWN DEFECTIVE, HARMFUL AND/OR TOXIC PRODUCTS OFF THE GLOBAL MARKET
This work is 100% independent. I am NOT a victim, NOT a lawyer, NOT paid by anyone other than visitors to the site. And no, I do not own any stock in Johnson & Johnson.

Content List
100+ articles of harm and corruption by Johnson & Johnson and subsidiary products.
Click for content list...

Glad to see you :o)
This web site currently has the attention of:
United States Air Force
US Senate
US Department of Defense
US Department of Justice
US Homeland Security
The Bank of New York Mellon Corp
Lloyds Banking Group PLC
Royal Bank of Canada
Bank of America
Harris Trust & Savings Bank
Deutsche Bank
Macquarie Bank
PNC Bank
Crédit Agricole Bank
Royal Bank of Scotland
Raymond James Financial
BlackRock Financial Management
...and many, many more from all over the world ;o)
Feel free to browse list of notable visitors to the web site.
Gifts of support are always very much appreciated...
Thank you,

Sponsored in part by...
Risperdal Boys Project Undisclosed to patients, Risperdal causes breast growth in boys.
----- / / -----
Examining Medicine An in-depth comprehensive, frequently updated look at extreme risks and permanent brain damage caused by psychiatric drugs.
----- / / -----
Fiddaman Blog Bob Fiddaman has been writing about the dangers of antidepressants since 2006. In 2011 he was presented with two human rights awards from the Citizens Commission on Human Rights.
----- / / -----
Special Needs Advocate Power Join me as we work hard to ensure what our very special children need.

Johnson & Johnson Consumer Sales Suffer Even More With Products Suspended in South Korea and India
JNJ Consumer Sales will continue to drop with hefty penalties in South Korea for Children's Tylenol recall and India for carcinogen in baby powder.

Keywords: j&j, JNJ, johnson and johnson, johnson & johnson, south, korea, india, recall
Date Created/Edited: 2013, May 21

Most Recent Content....
Second Quarter 2017 Lawsuits Against Johnson & Johnson Stable, BUT NOT All-Inclusive (2017, August 8)
Lawsuits against Johnson & Johnson in United States holding at 106,600! DOES NOT INCLUDE ALL PRODUCTS FACING LAWSUITS OR LAWUITS FILED OUTSIDE THE UNITED STATES!
Johnson & Johnson Tylenol Massacre
From dead babies to killer liver damage to autism to dimentia, harmful effects of Tylenol creates a massive flood of permanently injured and sometimes dead, victims.
Special Sections....
Mesh Files
Baby Powder (talc) Files
Risperdal Files
Levaquin Files
Xarelto Files
Hips Files
Letters to Shareholders
SEC Lawsuits Files

Recent Content....
Why President Trump Should Shut Down US FDA (2017, March 28)
Healthcare organizations around the world depend on US FDA decisions, however, profit, rather than safety, seems to be the primary motivation.
healthcare, health, obamacare, donald, trump, fda, fraud, kickback
The Fastest Growing Segment of Johnson & Johnson Is... (2016, November 15)
Growing over 29% in 2016, this is definitely the fastest growing segment of Johnson & Johnson!
johnson & johnson, J&J, JNJ, 2016, lawsuit, lawsuits, tort, liability
Third Quarter 2016 Lawsuits Against Johnson & Johnson Still Exploding! Now 99,000! (2016, November 15)
Growing every quarter, lawsuits against Johnson & Johnson in United States alone are now well over 99,000.
talc, risperdal, asr, hip, baby powder, tvt, mesh, lawsuit
The Difference Between Guinea Pig and Cash Cow (2016, September 27)
People keep saying pharma is using us as 'guinea pigs'. Uh, not quite. Take a minute to learn the difference between a 'guinea pig' and a 'cash cow'.
guinea pig, immunization, vaccination, profit, harm, autism, disability, asthma
Johnson & Johnson Victims at Risk of RE-Victimization (2016, August 22)
If you are currently a victim of a known harmful Johnson & Johnson subsidiary product and have high medical needs due to your injuries, you are at increased risk of becoming a victim of another known harmful Johnson & Johnson subsidiary product.
jnj, johnson and johnson, johnson & johnson, victim, mesh, hip, levaquin, risperdal
Wealthy Most at Risk for Harm by Johnson & Johnson and Subsidiary Products (2016, August 22)
If you make over $100,000 a year, you are far more likely than lower incomes to become a victim of a Johnson & Johnson and/or subsidiary product.
healthcare, cost, co-pay, risk, deductable, insurance, victim, salary
Second Quarter 2016 Lawsuits Against Johnson & Johnson Leap Again From 82,200 to 90,700 (2016, August 4)
Growing every quarter, lawsuits against Johnson & Johnson in United States alone are now well over 90,700.
talc, risperdal, asr, hip, baby powder, tvt, mesh, lawsuit
Johnson & Johnson Animas Defective Diabetes Devices (2016, August 4)
Gosh and golly gee willikers, yet another Johnson & Johnson subsidiary, Animas, totally sucks, jah?
Johnson and Johnson, Johnson & Johnson, animas, vibe, diabetes, insulin, device, pump
Johnson & Johnson Ethicrap, I Mean EthiCON, More JNJ JUNK (2016, July 25)
As I've mentioned, Johnson & Johnson has so many bad products I have to put a bunch in each article now to try to keep up. Now for EthiCON crap.
Johnson and Johnson, Johnson & Johnson, ethicon, harmonic ace, morcellator, physiomesh, secure strap, stapler
Johnson and Johnson Janssen Xarelto Slaughter (2016, July 8)
Overstating benefits, downplaying (or not disclosing) risks. Xarelto by Johnson and Johnson Janssen killing people left and right. Over 500 DEAD, 7,100 lawsuits already. Lovely, eh?
false, marketing, death, dead, xarelto, FDA, lawsuit, Janssen
This Convinced THREE Juries That Johnson and Johnson Talc Increases Ovarian Cancer (2016, May 14)
One very simple fact convinced THREE juries that Johnson & Johnson talc increases risk of developing ovarian cancer.
Johnson and Johnson, Johnson & Johnson, baby, powder, cancer, lawsuit, ovarian, talc
With consumer sales decreasing around the world, it's still not looking good for recovery of Johnson & Johnson consumer goods sales any time soon. As I noted in a previous article, Johnson & Johnson global consumer goods sales have been dropping for years. It's not a wonder. Three facilities had to be taken over by the FDA, one of which is totally shut down due to violations of FDA codes. These regulations are designed to protect consumers from companies, such as Johnson & Johnson, who do not maintain safe manufacturing facilities for our pharmaceutical supply.
Both China, in 2009, and India, in 2013, chose to remove Johnson & Johnson products from the shelves of their stores when it was discovered that they contain banned, allergenic, carcinogenic, mutagenic, ingredients. Unlike the United States government who obviously feels that the health of our American children is expendable, who simply continue to ignore the fact that there are carcinogens in baby and adult care products on the shelves of our stores. I don't know what's going on with China, but India has just begun the process of punishment for Johnson & Johnson for violating *their* regulations: they have suspended Johnson & Johnson from manufacturing certain baby products. Not exactly good for the new image of for all you love. What, pour carcinogens on our babies and ourselves? I don't think so.
After the recall of Children's Tylenol in South Korea this month, the South Korean equivalent to the United States FDA has decided on a suitable penalty for Johnson & Johnson. The company risked the health of the children of South Korea by failing to maintin proper quality control and testing of each batch. South Korea has suspended the manufacture of Children's Dye-Free Tylenol (5 months), Nizoral (4 months), Concerta (1 month), Ultacet (1 month) and Pariet (1 month). In addition, the CEO of Janssen Korea faces up to three years in prison if Johnson & Johnson is found guilty. (Resource: Janssen's Manufacturing Problems May Lead to Criminal Charges in Korea.

Add this to the recent recall in Australia of a stapling device, which can be added to all the lawsuits regarding known defective hips, and there's not going to be much improvement on the medical device sales profits after all the legal fees and settlements. The federal settlement alone on this one is over $2 billion. Also have to remember the mesh issues, another known defective device with law suits piling up.
And there are still issues with numerous drugs. Two of the worst are Risperdal and Levaquin. Geeze, there's such a backlog on the Levaquin settlements that after seven years, John Fratti has still not been offered a settlement after becoming permanantly disabled from the drug. So there goes more pharmaceutical profits.
Then, of course, there are people like me that seem to think other moms should be educated as to what's really in the products offered by Johnson & Johnson. Any mom that would knowingly allow another mom to use a product that can harm a child has got to be either cold or mentally ill.
Jeekers, boys and girls - it looks like Johnson & Johnson is not much more than corruption, lawsuits and toxic, harmful products. Oh, and Alex Gorsky, I really do think you need to resign immediately. Thanks ;o)
1. Emily Patterson (2013, May 12). Johnson & Johnson Consumer Sales Continue to Drop, 2011 to 2013 Johnson and Toxin. Retrieved from http://www.johnsonandtoxin.com/jnj_consumer_goods_sales.shtml
2. Dan Stanton (2013, May 20). Janssen's Manufacturing Problems May Lead to Criminal Charges in Korea in-Pharma Technologist. Retrieved from http://www.in-pharmatechnologist.com/Processing/Janssen-s-Manufacturing-Problems-May-Lead-to-Criminal-Charges-in-Korea
3. Brad Perriello (2013, May 13). Another recall for Johnson & Johnson Down Under Mass Device. Retrieved from http://www.massdevice.com/news/another-recall-johnson-johnson-down-under
4. Emily Patterson (2013, May 17). DePuy Metal on Metal Hips Dropped by Johnson & Johnson Due to Lack of Sales, Not Lack of Safety, WTF? Johnson and Toxin. Retrieved from http://www.johnsonandtoxin.com/mom_hips.shtml
5. Emily Patterson (2012, May 12). Johnson & Johnson Delaying $2.2 Billion DOJ Settlement to Reduce Risk of Liability to States and Victims Johnson and Toxin. Retrieved from http://www.johnsonandtoxin.com/jnj_delays_settlement.shtml
6. Emily Patterson (2012, May 3). Lawsuits Mounting for Harm by Johnson & Johnson Implanted Mesh Products Johnson and Toxin. Retrieved from http://www.johnsonandtoxin.com/mesh.shtml
7. Emily Patterson (2012, April 13). Johnson & Johnson Risperdal: Broken Laws and Side Effects Johnson and Toxin. Retrieved from http://www.johnsonandtoxin.com/risperdal.shtml
8. John Fratti. Hurt by Levaquin Levaquin Adverse Events. Retrieved from http://www.levaquinadversesideeffect.com/
9. Emily Patterson (2012, October 1). Johnson & Johnson Levaquin Victim Permanently Disabled John Fratti Johnson and Toxin. Retrieved from http://www.johnsonandtoxin.com/levaquin_john_fratti.shtml
10. Emily Patterson (Current). Twenty Years of KNOWN Carcinogens in J&J US Baby Care Products Finally Ends! Johnson and Toxin. Retrieved from http://www.johnsonandtoxin.com/products.shtml
11. Emily Patterson (2013, May 8). List of Reasons Johnson & Johnson CEO Alex Gorsky Should Immediately Resign Johnson and Toxin. Retrieved from http://www.johnsonandtoxin.com/alex_gorsky_resignation.shtml
All contents Copyright © 2012-2016 Emily Patterson / Johnson and Toxin. All rights reserved.
Web Site and Admin Info:
Privacy Policy
Site Statistics
Site Resources
Financial Disclosure

Recently Posted:
2015 Johnson & Johnson US Lawsuit Update: Jump from 48,500 to 56.500
Johnson & Johnson Plans to Expand Healthcare Cost Crisis and Product Liability in Asia
Who REALLY Pays for Drug Development? US TAXPAYERS - $21 BILLION for fiscal year 2014
Johnson & Johnson Janssen Xarelto Marketed In Violation of FDA Regulations
Johnson & Johnson Destroys Thousands of Files Related to Vaginal Mesh
Johnson & Johnson: The Global Lawsuit Company

Most Popular:
The Ever-Growing Number of Lawsuits Against Johnson & Johnson
Johnson & Johnson Credo Analysis
Johnson & Johnson $4 Billion for DePuy Hip Harm in U.S., With Lawsuits in at Least 4 More Countries